These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36375694)

  • 1. Characterisation of C101248: A novel selective THIK-1 channel inhibitor for the modulation of microglial NLRP3-inflammasome.
    Ossola B; Rifat A; Rowland A; Hunter H; Drinkall S; Bender C; Hamlischer M; Teall M; Burley R; Barker DF; Cadwalladr D; Dickson L; Lawrence JMK; Harvey JRM; Lizio M; Xu X; Kavanagh E; Cheung T; Sheardown S; Lawrence CB; Harte M; Brough D; Madry C; Matthews K; Doyle K; Page K; Powell J; Brice NL; Bürli RW; Carlton MB; Dawson LA
    Neuropharmacology; 2023 Feb; 224():109330. PubMed ID: 36375694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The two pore potassium channel THIK-1 regulates NLRP3 inflammasome activation.
    Drinkall S; Lawrence CB; Ossola B; Russell S; Bender C; Brice NB; Dawson LA; Harte M; Brough D
    Glia; 2022 Jul; 70(7):1301-1316. PubMed ID: 35353387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Expression of Two Pore Potassium Channel THIK-1 in Alzheimer's Disease: An Inflammatory Mechanism.
    Tang H; Sun Y; Fachim HA; Cheung TKD; Reynolds GP; Harte MK
    J Alzheimers Dis; 2023; 95(4):1757-1769. PubMed ID: 37718820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglial Ramification, Surveillance, and Interleukin-1β Release Are Regulated by the Two-Pore Domain K
    Madry C; Kyrargyri V; Arancibia-Cárcamo IL; Jolivet R; Kohsaka S; Bryan RM; Attwell D
    Neuron; 2018 Jan; 97(2):299-312.e6. PubMed ID: 29290552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of NLRP3 Inflammasome Activation: Its Role in the Treatment of Alzheimer's Disease.
    Zhang Y; Zhao Y; Zhang J; Yang G
    Neurochem Res; 2020 Nov; 45(11):2560-2572. PubMed ID: 32929691
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydromyricetin inhibits microglial activation and neuroinflammation by suppressing NLRP3 inflammasome activation in APP/PS1 transgenic mice.
    Feng J; Wang JX; Du YH; Liu Y; Zhang W; Chen JF; Liu YJ; Zheng M; Wang KJ; He GQ
    CNS Neurosci Ther; 2018 Dec; 24(12):1207-1218. PubMed ID: 29869390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway.
    Liu P; Zhou Y; Shi J; Wang F; Yang X; Zheng X; Wang Y; He Y; Xie X; Pang X
    Phytomedicine; 2023 Jul; 115():154801. PubMed ID: 37086707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyroptosis in Alzheimer's disease: cell type-specific activation in microglia, astrocytes and neurons.
    Moonen S; Koper MJ; Van Schoor E; Schaeverbeke JM; Vandenberghe R; von Arnim CAF; Tousseyn T; De Strooper B; Thal DR
    Acta Neuropathol; 2023 Feb; 145(2):175-195. PubMed ID: 36481964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Inhibitor Targeting NLRP3 Inflammasome Reduces Neuropathology and Improves Cognitive Function in Alzheimer's Disease Transgenic Mice.
    Kuwar R; Rolfe A; Di L; Blevins H; Xu Y; Sun X; Bloom GS; Zhang S; Sun D
    J Alzheimers Dis; 2021; 82(4):1769-1783. PubMed ID: 34219728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins.
    Deora V; Lee JD; Albornoz EA; McAlary L; Jagaraj CJ; Robertson AAB; Atkin JD; Cooper MA; Schroder K; Yerbury JJ; Gordon R; Woodruff TM
    Glia; 2020 Feb; 68(2):407-421. PubMed ID: 31596526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibiting the NLRP3 inflammasome with MCC950 promotes non-phlogistic clearance of amyloid-β and cognitive function in APP/PS1 mice.
    Dempsey C; Rubio Araiz A; Bryson KJ; Finucane O; Larkin C; Mills EL; Robertson AAB; Cooper MA; O'Neill LAJ; Lynch MA
    Brain Behav Immun; 2017 Mar; 61():306-316. PubMed ID: 28003153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ
    Zhang Y; Zhao Y; Zhang J; Gao Y; Li S; Chang C; Yu D; Yang G
    Neurosci Lett; 2021 Nov; 764():136206. PubMed ID: 34478813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microglial TLR4/NLRP3 Inflammasome Signaling in Alzheimer's Disease.
    Li Y; Chen X; Zhou M; Feng S; Peng X; Wang Y
    J Alzheimers Dis; 2024; 97(1):75-88. PubMed ID: 38043010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NLRP3 inflammasome inhibition and M1-to-M2 microglial polarization shifting via scoparone-inhibited TLR4 axis in ovariectomy/D-galactose Alzheimer's disease rat model.
    Ibrahim WW; Skalicka-Woźniak K; Budzyńska B; El Sayed NS
    Int Immunopharmacol; 2023 Jun; 119():110239. PubMed ID: 37137264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the interaction between microglial adenosine 2A receptor and NLRP3 inflammasome attenuates neuroinflammation posttraumatic brain injury.
    Du H; Li CH; Gao RB; Tan Y; Wang B; Peng Y; Yang N; Ning YL; Li P; Zhao Y; Zhou YG
    CNS Neurosci Ther; 2024 Jan; 30(1):e14408. PubMed ID: 37564004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble Aβ oligomers and protofibrils induce NLRP3 inflammasome activation in microglia.
    Lučiūnaitė A; McManus RM; Jankunec M; Rácz I; Dansokho C; Dalgėdienė I; Schwartz S; Brosseron F; Heneka MT
    J Neurochem; 2020 Dec; 155(6):650-661. PubMed ID: 31872431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β
    Ebrahimi T; Rust M; Kaiser SN; Slowik A; Beyer C; Koczulla AR; Schulz JB; Habib P; Bach JP
    J Neuroinflammation; 2018 Sep; 15(1):282. PubMed ID: 30261895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microglial function, INPP5D/SHIP1 signaling, and NLRP3 inflammasome activation: implications for Alzheimer's disease.
    Terzioglu G; Young-Pearse TL
    Mol Neurodegener; 2023 Nov; 18(1):89. PubMed ID: 38017562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct Molecular Mechanisms Underlying Potassium Efflux for NLRP3 Inflammasome Activation.
    Xu Z; Chen ZM; Wu X; Zhang L; Cao Y; Zhou P
    Front Immunol; 2020; 11():609441. PubMed ID: 33424864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibitors of NF-κB and P2X7/NLRP3/Caspase 1 pathway in microglia: Novel therapeutic opportunities in neuroinflammation induced early-stage Alzheimer's disease.
    Thawkar BS; Kaur G
    J Neuroimmunol; 2019 Jan; 326():62-74. PubMed ID: 30502599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.